ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Menlo Therapeutics Inc

Menlo Therapeutics Inc (MNLO)

1.35
0.00
(0.00%)
Closed 01 December 8:00AM
0.00
0.00
(0.00%)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
1.35
Bid
1.36
Offer
1.37
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
Previous Close
1.35
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
13,957,000
Dividend Yield
-
PE Ratio
-1.45
Earnings Per Share (EPS)
-2.04
Revenue
424k
Net Profit
-28.45M

About Menlo Therapeutics Inc

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
-

MNLO Latest News

Robbins Geller Rudman & Dowd LLP Announce Proposed Settlement in the Menlo Therapeutics Inc. Securities Settlement

The following statement is being issued by Robbins Geller Rudman & Dowd LLP regarding the Menlo Therapeutics Inc. Securities Settlement: SUPERIOR COURT OF THE STATE OF CALIFORNIA COUNTY OF...

Menlo Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results

REDWOOD CITY, Calif., March 03, 2020 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (Nasdaq: MNLO), a late-stage biopharmaceutical company focused on the development of serlopitant for the...

Menlo Therapeutics Announces Results from Phase 2 Trial of Serlopitant in Patients with Chronic Pruritus of Unknown Origin

REDWOOD CITY, Calif., Feb. 26, 2020 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (Nasdaq: MNLO), a late-stage biopharmaceutical company, today announced results from its Phase 2 clinical trial...

Menlo Therapeutics to Host Conference Call Tomorrow to Discuss Results from Phase 2 Trial of Serlopitant in Patients with Chr...

REDWOOD CITY, Calif., Feb. 25, 2020 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (Nasdaq: MNLO), a late-stage biopharmaceutical company, today announced it will host a conference call and webcast...

Menlo Therapeutics Announces Publication of Phase 2 Results for Serlopitant for the Treatment of Pruritus Associated with Pso...

REDWOOD CITY, Calif., Feb. 05, 2020 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ: MNLO), a late-stage biopharmaceutical company focused on the development of serlopitant for the treatment...

Menlo Therapeutics CEO to Participate in Fireside Chat at the Piper Jaffray 31st Annual Healthcare Conference

REDWOOD CITY, Calif., Nov. 27, 2019 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ: MNLO), a late-stage biopharmaceutical company focused on the development of serlopitant for the treatment...

SHAREHOLDER ALERT: WeissLaw LLP Investigates Foamix Pharmaceuticals Ltd.

SHAREHOLDER ALERT: WeissLaw LLP Investigates Foamix Pharmaceuticals Ltd. PR Newswire NEW YORK, Nov. 12, 2019 NEW YORK, Nov. 12, 2019 /PRNewswire/ -- WeissLaw LLP is investigating possible...

Menlo Therapeutics Reports Third Quarter 2019 Financial Results and Provides Program Updates

REDWOOD CITY, Calif., Oct. 31, 2019 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (Nasdaq: MNLO), a late-stage biopharmaceutical company focused on the development of serlopitant for the treatment...

Menlo Therapeutics Announces Completion of Enrollment in Two Phase 3 Trials of Serlopitant in Prurigo Nodularis

- Pivotal results expected in March/April 2020 - - Details of the program to be reviewed at company’s Investor Day today in NY - REDWOOD CITY, Calif., Oct. 29, 2019 (GLOBE NEWSWIRE) -- Menlo...

Menlo Therapeutics to Host Investor Day October 29, 2019

-Management to Review Late Stage Development, NDA-readiness and Commercial Opportunity of Serlopitant- -Discussion to Feature two Prominent Key Opinion Leaders Well Versed in the Unmet Needs of...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BSLKBolt Projects Holdings Inc
US$ 0.71
(139.86%)
80.81M
PRZOParaZero Technologies Ltd
US$ 1.24
(94.14%)
205.02M
AIEVThunder Power Holdings Inc
US$ 0.47
(87.25%)
122.71M
PASGPassage Bio Inc
US$ 1.13
(69.52%)
15.44M
EPOWSunrise New Energy Company Ltd
US$ 1.06
(45.21%)
314.9k
APLTApplied Therapeutics Inc
US$ 2.03
(-76.31%)
43.9M
TGLTreasure Global Inc
US$ 0.2944
(-29.08%)
1.85M
PROCProcaps Group SA
US$ 1.51
(-27.75%)
106.08k
SHOTWSafety Shot Inc
US$ 0.104
(-20.00%)
1.43k
MONDMondee Holdings Inc
US$ 0.7102
(-19.59%)
297.63k
PRZOParaZero Technologies Ltd
US$ 1.24
(94.14%)
205.02M
NVDANVIDIA Corporation
US$ 138.25
(2.15%)
141.86M
AIEVThunder Power Holdings Inc
US$ 0.47
(87.25%)
122.71M
RGTIRigetti Computing Inc
US$ 3.05
(27.08%)
116.98M
MARAMARA Holdings Inc
US$ 27.42
(1.86%)
89.54M

Discussion

View Full Feed
jeunke22 jeunke22 4 minutes ago
You are correct. Apparently a double count put it at 44 mio in the Fintel reporting early November, but it was corrected to 40 mio.
LWLG
infamous infamous 11 minutes ago
Right
SFIO
Richie R Richie R 12 minutes ago
Looking for a winner here!
nowwhat2 nowwhat2 15 minutes ago
https://investorshub.advfn.com/uimage/uploads/2024/12/1/oozwgXRP_111111_30_5d_730pm_news_event_Q_TA.jpg



https://investorshub.advfn.com/uimage/uploads/2024/12/1/nszyaXRP_111111_30_5d_10pm_news_event_Q_TA.jpg




5 HOURS EARLIER ;
XRPUSD
cash-talks-bs-walks cash-talks-bs-walks 24 minutes ago
Time to make some $$$$$$$
PGHL
cb521 cb521 26 minutes ago
In His Time. Very excited at what’s happening, not hoping for anything. Chilling
ZNOG
CorsairNavigator20 CorsairNavigator20 32 minutes ago
Just my thoughts are the phase 1 data could drive us to $250M. Phase2 would not be completed in 2025 and I would be hoping 500-750M. The real driver would be the pancreatic cancer study next year. That phase 1 data could drive it since the study group could have 3-6 months to end of life. I look
MRKR
nowwhat2 nowwhat2 39 minutes ago
You LIKE our new CEO ?.....I dunno.....
I had to fix her hair ;
https://www.news-journal.com/international-battery-metals-ibat-announces-iris-jancik-takes-helm-as-ceo-to-lead-expansion-of/article_3a9f211a-8b57-5c12-beb5-d202cf389a6a.html

https://investorshub.advfn.com/
IBATF
RichieBoy RichieBoy 39 minutes ago
Are you trying to establish the premise that OTCN has stopped screwing over Retail. Or is this pure speculation. 🤹
AFFU
XMaster2023 XMaster2023 40 minutes ago
RobotDroid,
Speaking of GIGO, you win.
NWBO
FrostyStar1 FrostyStar1 42 minutes ago
Well lets see, the only time Ukraine didn't get smaller was when Trump was in the White House. Obama gave Putin Crimea and Biden let Putin take Eastern Ukraine.

The only time North Korea wasn't firing off rockets was when Trump was president.

Biden abandoned 11 embassi
STHC
RichieBoy RichieBoy 43 minutes ago
Has Bjarne delineated any so called strategic alternatives yet?
SONXD
Stock_Barber Stock_Barber 43 minutes ago
Full stream ahead

Yes Indeed!

https://external-content.duckduckgo.com/iu/?u=https%3A%2F%2Fsc01.alicdn.com%2Fkf%2FHTB1P8EOSXXXXXX9XVXXq6xXFXXXC%2F230436576%2FHTB1P8EOSXXXXXX9XVXXq6xXFXXXC.jpg&f=1&nofb=1&ipt=7b24b84b96f71b702016fae9367c98caa7215a646b3621ab4f1f5c6ca645812c
DBMM
sage4 sage4 44 minutes ago
I'm just amazed that he has posted total 5290 messages for the last 7 years (or average 2 posts everyday including weekends and holidays) on AVXL- a small bio company that he even does not believe in. What does drive him in doing such achievement? Go figure......
Copied from his very 1st po
AVXL
mailman69 mailman69 45 minutes ago
We will see over the next four years what happens I guarantee you he will get rid of a lot of beer, credit, red tape, and cause more inflation. More price increases less regulations because of it, and will hurt the economy so bad that we may not recover.
STHC
gawti88 gawti88 47 minutes ago
take 3s out ill slap 100k shares
CEOS
RichieBoy RichieBoy 47 minutes ago
Apart from BIOL purchase Agreement expenses it appears SONXD hasn't received a nickel from any Intellectual Property case as the plaintiff. In all honesty I'm surprised Bjorne raised his bid against Korean bid.

I hunch SONXD left TDO Software to Quebec's Valsoft remaining a Joint Vent
SONXD
FrostyStar1 FrostyStar1 47 minutes ago
Tariffs already exist on over 50 countries around the world
Joe Biden kept Trump's tariffs
Joe Biden increased Tariffs
Joe Biden put 100% tariffs on EV imports even though we are suppose to be saving the planet.

Just stop with your nonsense.
STHC
mailman69 mailman69 49 minutes ago
Get back to the stock I believe overtime the stock will turn around and become current and when it becomes current, I think we can go from one cent to as much as a dollar over a certain period of time but these things do take time
STHC

Your Recent History

Delayed Upgrade Clock